Comparison of Two Forms of Transcutaneous Electrical Stimulation in Overactive Bladder
12. november 2018 opdateret af: Hospital de Clinicas de Porto Alegre
Comparison of Parasacral Transcutaneous Electrical Stimulation With Transcutaneous Posterior Tibial Nerve Stimulation in Women With Overactive Bladder: a Randomized Clinical Trial
Aim: To compare the effects of parasacral transcutaneous electrical stimulation with transcutaneous posterior tibial nerve stimulation on the symptoms of Overactive Bladder in women.
Study's hypothesis: The use of the parasacral transcutaneous electrical stimulation technique presents better results regarding the remission of overactive bladder symptoms in relation to transcutaneous posterior tibial nerve stimulation.
Studieoversigt
Status
Ukendt
Betingelser
Detaljeret beskrivelse
Search location: The data will collected at the Ambulatory of Urogynecology and Obstetrics of Porto Alegre Clinical Hospital (HCPA), where the activities of Pelvic Physiotherapy are performed
Main outcome: to measure changes in urinary urgency and quality of life.
Secondary outcome: to measure changes in the severity of urinary incontinence and the symptom bother.
Undersøgelsestype
Interventionel
Tilmelding (Forventet)
68
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Rio Grande Do Sul
-
Porto Alegre, Rio Grande Do Sul, Brasilien
- Rekruttering
- Suzana Mallmann
-
Kontakt:
- Mallmann
- Telefonnummer: +5551996261820
- E-mail: suzana_mallmann@hotmail.com
-
Ledende efterforsker:
- José Geraldo Lopes Ramos
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Kvinde
Beskrivelse
Inclusion Criteria:
- Diagnosis of overactive bladder with or without the presence of urinary incontinence.
- Understand the instruments used in the research.
Exclusion Criteria:
- Urinary tract infection
- Neurological disease
- Other previous treatment in the last four weeks
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Parasacral
Parasacral Transcutaneous Electrical Stimulation Group: participants in this group will receive two self-adhesive electrodes and will be instructed to position them in the sacral region.
Current parameters will be: 10 hertz frequency, 700μs wavelength, 20 minute therapy duration, 3x frequency in the week.
The treatment will be at home for 6 weeks.
|
Electrical stimulation with surface electrodes on the sacral roots of S3 that produce inferior urinary tract neuromodulation.
|
|
Aktiv komparator: Posterior Tibial Nerve
Transcutaneous Posterior Tibial Nerve Stimulation Group: participants in this group will receive a neoprene ankle brace that will be connected to the electrostimulator.
Current parameters will be: 10 hertz frequency, 700μs wavelength, 20 minute therapy duration, 3x frequency in the week.
The treatment will be at home for 6 weeks.
|
Electrical stimulation with surface electrodes through the activation of peripheral afferent nerves that produce inferior urinary tract neuromodulation
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Efficacy of treatment in quality of life
Tidsramme: six weeks
|
Application of the King's Health Questionnaire (KHQ).
KHQ is an instrument for measuring quality of life in people diagnosed with urinary incontinence, consisting of 30 objective questions distributed in 9 domains.
In each question, values are assigned according to the intensity of the patient's complaint (0 = not applicable, 1 = no; 2 = a little / sometimes, 3 = more or less / several times, 4 = a lot / always).
The final score is calculated individually for each domain and ranges from 0 to 100, the highest score being related to a poorer quality of life.
|
six weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Severity of urinary incontinence
Tidsramme: six weeks
|
Application of the Incontinence Severity Index.
It is a brief instrument, consisting of two questions regarding the frequency and amount of urinary loss.
The final score obtained by multiplying the frequency scores by the amount of urinary loss allows the incontinence urinary to be classified as mild (final score 1-2), moderate (final score 3-6 ), severe (final score 8-9) and very severe (final score 12).
|
six weeks
|
|
Severity of overactive bladder symptoms
Tidsramme: six weeks
|
Application of the Symptom Bother Scale.
It instrument asks how bothered the patient is by the 4 hallmark symptoms of overactive bladder: urinary frequency, urgency, nocturia, and urge incontinence.
Patients respond on a 6-point Likert scale ranging from 0 (not at all) to 5 (a very great deal), with a maximum possible score of 40, calculated by adding all responses.
|
six weeks
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Efterforskere
- Ledende efterforsker: Jose Geraldo Lopes Ramos, Hospital de Clinicas de Porto Alegre
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
25. januar 2018
Primær færdiggørelse (Forventet)
1. oktober 2019
Studieafslutning (Forventet)
1. oktober 2019
Datoer for studieregistrering
Først indsendt
31. oktober 2018
Først indsendt, der opfyldte QC-kriterier
12. november 2018
Først opslået (Faktiske)
15. november 2018
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
15. november 2018
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
12. november 2018
Sidst verificeret
1. oktober 2018
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 17-0056
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Uafklaret
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .